Windtree Therapeutics Inc (WINT)
4.37
-0.12
(-2.67%)
USD |
NASDAQ |
May 20, 16:00
5.00
+0.63
(+14.42%)
After-Hours: 04:28
Windtree Therapeutics 1 Year Total Returns (Daily): -83.71% for May 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 20, 2024 | -83.71% |
May 17, 2024 | -83.26% |
May 16, 2024 | -83.18% |
May 15, 2024 | -82.84% |
May 14, 2024 | -85.45% |
May 13, 2024 | -85.91% |
May 10, 2024 | -85.85% |
May 09, 2024 | -85.98% |
May 08, 2024 | -83.94% |
May 07, 2024 | -84.82% |
May 06, 2024 | -83.18% |
May 03, 2024 | -82.85% |
May 02, 2024 | -82.31% |
May 01, 2024 | -83.03% |
April 30, 2024 | -82.84% |
April 29, 2024 | -82.05% |
April 26, 2024 | -83.49% |
April 25, 2024 | -84.86% |
April 24, 2024 | -86.49% |
April 23, 2024 | -85.71% |
April 22, 2024 | -86.30% |
April 19, 2024 | -93.90% |
April 18, 2024 | -94.90% |
April 17, 2024 | -95.15% |
April 16, 2024 | -90.38% |
Date | Value |
---|---|
April 15, 2024 | -90.31% |
April 12, 2024 | -90.29% |
April 11, 2024 | -91.62% |
April 10, 2024 | -91.98% |
April 09, 2024 | -92.43% |
April 08, 2024 | -91.63% |
April 05, 2024 | -91.82% |
April 04, 2024 | -91.70% |
April 03, 2024 | -92.64% |
April 02, 2024 | -92.63% |
April 01, 2024 | -92.67% |
March 28, 2024 | -92.32% |
March 27, 2024 | -92.40% |
March 26, 2024 | -92.90% |
March 25, 2024 | -92.77% |
March 22, 2024 | -92.55% |
March 21, 2024 | -92.57% |
March 20, 2024 | -92.44% |
March 19, 2024 | -92.80% |
March 18, 2024 | -92.98% |
March 15, 2024 | -92.95% |
March 14, 2024 | -92.12% |
March 13, 2024 | -91.58% |
March 12, 2024 | -91.53% |
March 11, 2024 | -91.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.47%
Minimum
Feb 22 2024
54.72%
Maximum
Feb 18 2020
-59.81%
Average
-74.10%
Median
Aug 25 2022
1 Year Total Returns (Daily) Benchmarks
Lexicon Pharmaceuticals Inc | -41.20% |
AIM ImmunoTech Inc | -12.49% |
Perspective Therapeutics Inc | 235.2% |
Protalix BioTherapeutics Inc | -41.18% |
Armata Pharmaceuticals Inc | 86.47% |